
Consensus
The community sees this as very unlikely for Injective at 23%, based on 6 forecasts. Forecasters are in moderate agreement.
Resolves YES if Injective is down more than 84% 12 months out versus its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole inj discussion →